BENEFIT-RISK RATIO IN THE TREATMENT OF TACHYARRHYTHMIAS - A CLINICAL JUDGMENT

被引：2

作者：

BENDER, F

机构：

来源：

关键词：

D O I：

10.2165/00003495-198500294-00013

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：65 / 67

页数：3

共 10 条

[1] BENDER F, 1982, MUNCHEN MED WOCHEN, V124, P387
[2] BENDER F, 1980, CLIN INVEST MED, V3, P21
[3] CRONHEIM GE, 1984, FLECAINID EXPT BEFUN, P211
[4] FEINSTEIN A, 1974, ADVERSE DRUG REACTIO
[5] EXTRACARDIAC ADVERSE-EFFECTS OF FLECAINIDE
GENTZKOW, GD
SULLIVAN, JY
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (05) : B101 - B105
[6] GULKER G, 1982, CALCIUMANTAGONISTEN, P278
[7] EFFECTS OF FLECAINIDE ON VENTRICULAR-FUNCTION - CLINICAL AND EXPERIMENTAL CORRELATIONS
JOSEPHSON, MA
IKEDA, N
SINGH, BN
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (05) : B95 - B100
[8] Knipping W, 1980, Med Klin, V75, P108
[9] MAY FE, 1977, CLIN PHARMACOL THER, V22, P322
[10] FLECAINIDE - ITS PROARRHYTHMIC EFFECT AND EXPECTED CHANGES ON THE SURFACE ELECTROCARDIOGRAM
MORGANROTH, J
HOROWITZ, LN
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (05) : B89 - B94